XML 56 R38.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Business Segment and Geographic Data Information (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Segment Reporting Information |
Information Concerning Consolidated Operations by Business Segment | Consolidated Operations by Business Segment
| Year Ended December 31
| 2023 |  | 2022 |  | 2021
NET SALES(a) |  |  |  |  |
Personal Care | $ | 10,691 |  |  | $ | 10,622 |  |  | $ | 10,267 |
Consumer Tissue | 6,290 |  |  | 6,243 |  |  | 6,034 |
K-C Professional | 3,404 |  |  | 3,256 |  |  | 3,072 |
Corporate & Other | 46 |  |  | 54 |  |  | 67 |
TOTAL NET SALES | $ | 20,431 |  |  | $ | 20,175 |  |  | $ | 19,440 |
OPERATING PROFIT(b) |
Personal Care | $ | 1,890 |  |  | $ | 1,787 |  |  | $ | 1,856 |
Consumer Tissue | 976 |  |  | 806 |  |  | 888 |
K-C Professional | 665 |  |  | 457 |  |  | 404 |
Corporate & Other(c) | (1,118) |  |  | (412) |  |  | (559) |
Other (income) and expense, net(d) | 69 |  |  | (43) |  |  | 28 |
TOTAL OPERATING PROFIT | $ | 2,344 |  |  | $ | 2,681 |  |  | $ | 2,561 |
(a)Net sales in the U.S. to third parties totaled $10,362, $9,848 and $9,285 in 2023, 2022 and 2021, respectively. No other individual country's net sales exceeds 10 percent of total net sales. (b) Segment operating profit excludes Other (income) and expense, net and income and expenses not associated with the business segments. (c) Corporate & Other in 2023 includes divestiture-related costs associated with the sale of our Brazil tissue and K-C Professional business of $30 and the charges related to the impairment of intangible assets of $658. In 2022, it includes transaction and integration costs of $21 related to the acquisition of a controlling interest in Thinx, and in 2021, it includes charges of $265 related to the 2018 Global Restructuring Program. Restructuring charges in 2021 related to the Personal Care, Consumer Tissue and K-C Professional business segments were $104, $118 and $40, respectively. (d) Other (income) and expense, net in 2023 includes the gain of $74 related to the sale of our Brazil tissue and K-C Professional business, and in 2022 includes the non-cash, non-recurring gain of $85 related to the acquisition of a controlling interest in Thinx.
| Personal Care |  | Consumer Tissue |  | K-C Professional |  | Corporate & Other |  | Total
Depreciation and Amortization |  |  |  |  |  |  |  |  |
2023 | $ | 387 |  |  | $ | 236 |  |  | $ | 127 |  |  | $ | 3 |  |  | $ | 753 |
2022 | 375 |  |  | 251 |  |  | 125 |  |  | 3 |  |  | 754 |
2021 | 355 |  |  | 291 |  |  | 116 |  |  | 4 |  |  | 766 |
Capital Spending |  |  |  |  |  |  |  |  |
2023 | 342 |  |  | 285 |  |  | 123 |  |  | 16 |  |  | 766 |
2022 | 442 |  |  | 280 |  |  | 142 |  |  | 12 |  |  | 876 |
2021 | 536 |  |  | 303 |  |  | 157 |  |  | 11 |  |  | 1,007 |
Assets |  |  |  |  |  |  |  |  |
2023 | 7,999 |  |  | 4,935 |  |  | 2,507 |  |  | 1,903 |  |  | 17,344 |
2022 | 9,086 |  |  | 5,048 |  |  | 2,675 |  |  | 1,161 |  |  | 17,970 |
2021 | 8,890 |  |  | 5,083 |  |  | 2,650 |  |  | 1,214 |  |  | 17,837 |
Sales of Principal Products | Sales of Principal Products
(Billions of dollars) |  | 2023 |  | 2022 |  | 2021
Baby and child care products |  | $ | 7.1 |  |  | $ | 7.2 |  |  | $ | 7.2 |
Consumer tissue products |  | 6.3 |  |  | 6.2 |  |  | 6.0 |
Away-from-home professional products |  | 3.4 |  |  | 3.3 |  |  | 3.1 |
All other |  | 3.6 |  |  | 3.5 |  |  | 3.1 |
Consolidated |  | $ | 20.4 |  |  | $ | 20.2 |  |  | $ | 19.4 |

X
- Definition Schedule Of Sales Of Principal Products [Text Block] + References No definition available. + Details
Name: | kmb_ScheduleOfSalesOfPrincipalProductsTextBlock
Namespace Prefix: | kmb_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration